Review



version 8.0.0.783 (r2012b)  (MathWorks Inc)


Bioz Verified Symbol MathWorks Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    MathWorks Inc version 8.0.0.783 (r2012b)
    A summary of the studies included in the scoping review, outlining the pharmaceutical drugs involved, therapeutic indications, in silico tools used, and the key findings related to bioequivalence.
    Version 8.0.0.783 (R2012b), supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/version 8.0.0.783 (r2012b)/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    version 8.0.0.783 (r2012b) - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Advancements in Virtual Bioequivalence: A Systematic Review of Computational Methods and Regulatory Perspectives in the Pharmaceutical Industry"

    Article Title: Advancements in Virtual Bioequivalence: A Systematic Review of Computational Methods and Regulatory Perspectives in the Pharmaceutical Industry

    Journal: Pharmaceutics

    doi: 10.3390/pharmaceutics16111414

    A summary of the studies included in the scoping review, outlining the pharmaceutical drugs involved, therapeutic indications, in silico tools used, and the key findings related to bioequivalence.
    Figure Legend Snippet: A summary of the studies included in the scoping review, outlining the pharmaceutical drugs involved, therapeutic indications, in silico tools used, and the key findings related to bioequivalence.

    Techniques Used: In Silico

    Pie chart depicting the distribution of in silico modeling tools used in virtual bioequivalence studies, as identified in the systematic review. The chart highlights the percentage utilization of each tool, including SimCYP ® , PK-Sim ® , GastroPlus™, Phoenix WinNonlin™, and MATLAB ® .
    Figure Legend Snippet: Pie chart depicting the distribution of in silico modeling tools used in virtual bioequivalence studies, as identified in the systematic review. The chart highlights the percentage utilization of each tool, including SimCYP ® , PK-Sim ® , GastroPlus™, Phoenix WinNonlin™, and MATLAB ® .

    Techniques Used: In Silico



    Similar Products

    version 8.0.0.783 (r2012b)  (MathWorks Inc)
    90
    MathWorks Inc version 8.0.0.783 (r2012b)
    A summary of the studies included in the scoping review, outlining the pharmaceutical drugs involved, therapeutic indications, in silico tools used, and the key findings related to bioequivalence.
    Version 8.0.0.783 (R2012b), supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/version 8.0.0.783 (r2012b)/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    version 8.0.0.783 (r2012b) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    version 8.0.0.783, r2012b  (MathWorks Inc)
    90
    MathWorks Inc version 8.0.0.783, r2012b
    A summary of the studies included in the scoping review, outlining the pharmaceutical drugs involved, therapeutic indications, in silico tools used, and the key findings related to bioequivalence.
    Version 8.0.0.783, R2012b, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/version 8.0.0.783, r2012b/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    version 8.0.0.783, r2012b - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    software, version 8.0.0.783 – r2012b  (MathWorks Inc)
    90
    MathWorks Inc software, version 8.0.0.783 – r2012b
    A summary of the studies included in the scoping review, outlining the pharmaceutical drugs involved, therapeutic indications, in silico tools used, and the key findings related to bioequivalence.
    Software, Version 8.0.0.783 – R2012b, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/software, version 8.0.0.783 – r2012b/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    software, version 8.0.0.783 – r2012b - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    matlab® r2012b version 8.0.0.783  (MathWorks Inc)
    90
    MathWorks Inc matlab® r2012b version 8.0.0.783
    A summary of the studies included in the scoping review, outlining the pharmaceutical drugs involved, therapeutic indications, in silico tools used, and the key findings related to bioequivalence.
    Matlab® R2012b Version 8.0.0.783, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/matlab® r2012b version 8.0.0.783/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    matlab® r2012b version 8.0.0.783 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    software version 8.0.0.783 - r2012b  (MathWorks Inc)
    90
    MathWorks Inc software version 8.0.0.783 - r2012b
    A summary of the studies included in the scoping review, outlining the pharmaceutical drugs involved, therapeutic indications, in silico tools used, and the key findings related to bioequivalence.
    Software Version 8.0.0.783 R2012b, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/software version 8.0.0.783 - r2012b/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    software version 8.0.0.783 - r2012b - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    A summary of the studies included in the scoping review, outlining the pharmaceutical drugs involved, therapeutic indications, in silico tools used, and the key findings related to bioequivalence.

    Journal: Pharmaceutics

    Article Title: Advancements in Virtual Bioequivalence: A Systematic Review of Computational Methods and Regulatory Perspectives in the Pharmaceutical Industry

    doi: 10.3390/pharmaceutics16111414

    Figure Lengend Snippet: A summary of the studies included in the scoping review, outlining the pharmaceutical drugs involved, therapeutic indications, in silico tools used, and the key findings related to bioequivalence.

    Article Snippet: Nakamura, T. et al. [ ], 2018 , PubMed , Tamoxifen , Anticancer , MATLAB version 8.0.0.783 (R2012b).

    Techniques: In Silico

    Pie chart depicting the distribution of in silico modeling tools used in virtual bioequivalence studies, as identified in the systematic review. The chart highlights the percentage utilization of each tool, including SimCYP ® , PK-Sim ® , GastroPlus™, Phoenix WinNonlin™, and MATLAB ® .

    Journal: Pharmaceutics

    Article Title: Advancements in Virtual Bioequivalence: A Systematic Review of Computational Methods and Regulatory Perspectives in the Pharmaceutical Industry

    doi: 10.3390/pharmaceutics16111414

    Figure Lengend Snippet: Pie chart depicting the distribution of in silico modeling tools used in virtual bioequivalence studies, as identified in the systematic review. The chart highlights the percentage utilization of each tool, including SimCYP ® , PK-Sim ® , GastroPlus™, Phoenix WinNonlin™, and MATLAB ® .

    Article Snippet: Nakamura, T. et al. [ ], 2018 , PubMed , Tamoxifen , Anticancer , MATLAB version 8.0.0.783 (R2012b).

    Techniques: In Silico